Study design and participants
malignant breast diseases, depression, bleeding
SECONDARY, DISEASES, BLEEDING
This randomized controlled trial was conducted on 70 pregnant women admitted to Tabriz health centers in 2020. The inclusion criteria for this study were a minimum of secondary education, a gestational age of 25–28 weeks, a first or second pregnancy, being a singleton, no diseases affecting the pregnancy process, not using drugs that affect mental-psychological problems, and no history of severe depression. Women who had a history of bleeding during the second stage of pregnancy, as well as a history of malignant breast diseases, were excluded from the study.